NCT06571734 2026-01-09XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable LeiomyosarcomaNorthwestern UniversityPhase 2 Recruiting29 enrolled
NCT06528769 2025-09-30Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced LeiomyosarcomaOhio State University Comprehensive Cancer CenterPhase 2 Recruiting16 enrolled